Publications by authors named "Marcia Kuklinski"

Article Synopsis
  • A study evaluated 328 patients with hormone receptor-positive, HER2/neu-negative breast cancer, consisting of 34.8% African American (AA) and 65.2% White American (WA) participants.
  • The average age of patients was 60 years, with similar tumor sizes between AA (1.6 cm) and WA (1.7 cm), although AA had a higher average BMI (33 vs. 29.8).
  • Distant recurrence rates were low for both groups (1.0% for AA and 1.6% for WA), indicating that the recurrence score (RS) utility is comparable between AA and WA patients, despite no significant differences in chemotherapy delivery.
View Article and Find Full Text PDF

Introduction: The 21-gene expression profile [Oncotype DX Recurrence Score (RS)] stratifies benefit from adjuvant chemotherapy in hormone receptor (HR)-positive, HER2/neu-negative, node-negative breast cancer. It is not routinely applied to predict neoadjuvant chemotherapy (NACT) response; data in diverse patient populations also are limited. We developed a statistical model based on standard clinicopathologic features to identify high-risk cases (RS > 30) and then evaluated ability of predicted high RS to predict for NACT downstaging.

View Article and Find Full Text PDF